N-[[4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl]methyl]-2-fluoroaniline N-[[4-([1,2,4]三唑并[1,5-a]吡啶-6-基)-5-(6-甲基吡啶-2-基)-1H-咪唑-2-基]甲基]-2-氟苯胺
CAS 1352608-82-2 MFCD452608822
化学结构图
SMILES: Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1
化学属性
| Mol. Weight | 399 |
|---|---|
| Appearance | white solid powder |
| Solubility | Soluble in DMSO, not in water |
| Mol. Formula | C22H18FN7 |
别名和识别编码
| Chemical Name Translation | N-[[4-([1,2,4]三唑并[1,5-a]吡啶-6-基)-5-(6-甲基吡啶-2-基)-1H-咪唑-2-基]甲基]-2-氟苯胺 |
|---|---|
| Chemical Name | N-[[4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl]methyl]-2-fluoroaniline |
| Formula | C22H18FN7 |
| Synonym | TEW7197; TEW 7197; TEW-7197; Vactosertib |
| IUPAC Name | N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline |
| InChIKey | FJCDSQATIJKQKA-UHFFFAOYSA-N |
| InChI | InChI=1S/C22H18FN7/c1-14-5-4-8-18(27-14)22-21(15-9-10-20-25-13-26-30(20)12-15)28-19(29-22)11-24-17-7-3-2-6-16(17)23/h2-10,12-13,24H,11H2,1H3,(H,28,29) |
| Canonical SMILES | FC1=CC=CC=C1NCC2=NC(C3=CN4C(C=C3)=NC=N4)=C(C5=NC(C)=CC=C5)N2 |
| MDL Number | |
| CAS Number | 1352608-82-2 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
产品应用
- Vactosertib, also known as TEW-7197 is a potent ALK5 inhibitor. TEW-7197 showed potent in vivo anti-metastatic activity, indicating its potential for use as an anti-cancer therapy. EW-7197 inhibits TGF-β/Smad signaling. EW-7197 abrogates TGF-β1-induced tumor cell migration and invasion. EW-7197 inhibits breast cancer metastasis to the lung.EW-7197 prolongs the life span of BALB/c 4T1 mice via inhibition of EMT. EW-7197 inhibits metastasis and enhances the activity of cytotoxic T lymphocytes (CTLs) in 4T1 orthotopic grafted mice.
安全信息
GHS Symbol
